PyroGenesis Canada (NASDAQ:PYR) reported $4.21 million in sales this quarter. This is a 32.85 percent decrease over sales of $6.26 million the same period last year.
Companies Reporting Before The Bell
• AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX:PYR) (NASDAQ:PYR) (FRA: 8PY), a high-tech company (hereinafter referred to as the "Company" or "PyroGenesis"), that designs, develops,
PyroGenesis Canada Inc. (http://pyrogenesis.com) (NASDAQ:PYR) (TSX:PYR) (FRA: 8PY), a high-tech Company (hereinafter referred to as the "Company" or "PyroGenesis"), that designs, develops,